Please go ahead. Good morning, and welcome to Elevance Health fourth-quarter 2024 earnings conference call. My name is Nathan Rich, Vice President of Investor Relations. With us this morning on ...

I am updating my analysis on Elevance Health (NYSE:ELV) in light of Q4 and full-year 2024 earnings which were released pre-market on Thursday, January 23rd. I had previously rated Elevance Health ...

Artisan Select Equity Fund stated the following regarding Elevance Health, Inc. (NYSE:ELV) in its Q4 2024 investor letter: "Elevance Health, Inc. (NYSE:ELV) took a couple of blows this quarter.

Elevance Health executives told investors on Thursday morning that they're confident in their 7% to 9% growth targets in Medicare Advantage based on early data coming out of the annual enrollment ...

Please go ahead. Nathan Rich-- Vice President, Investor Relations Good morning, and welcome to Elevance Health fourth quarter 2024 earnings call. My name is Nathan Rich, vice president of investor ...

Elevance Health, Inc. ELV reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7% ...

Please go ahead. Good morning, and welcome to Elevance Health's fourth quarter 2024 earnings call. My name is Nathan Rich, Vice President of Investor Relations. With us this morning on the ...

Steve Tanal-- Chief Investor Relations Officer, Corporate Financial Planning and Analysis Good morning, and welcome to Elevance Health's second-quarter 2024 earnings ... close Q3, Q4 of this ...

Elevance Health Inc. (NYSE:ELV) Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings ...